House E&C Staff Not Negotiating With Senate Finance On Rx Pricing

Democratic staff of the House Energy & Commerce Committee are not negotiating on drug pricing with staff of the Senate Finance Committee, sources say, even though Finance Chair Chuck Grassley (R-IA) said bicameral drug-pricing talks would occur in August. The Energy & Commerce Committee has jurisdiction over Medicare Part D, the focus of the most controversial provisions in the Finance drug pricing package. Staff of the House Energy & Commerce Committee have talked about health care extenders with Finance staff...